Actavis to acquire pharmaceutical company Durata Therapeutics

The U.S. Federal Trade Commission has cleared the Actavis proposal to acquire pharmaceutical company Durata Therapeutics, according to a PBRHome report.

Advertisement

Actavis has a broad pharmaceuticals portfolio in areas including gastroenterology, women’s health, urology and more. The company operates more than 30  manufacturing and distribution facilities.

More articles on gastroenterology:
5 must-reads for the forward-thinking gastroenterology leader
Dr. Lawrence Kosinski: 4 thoughts on the future of gastroenterology
EndoChoice considers $100M+ IPO

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.